Keyword Analysis & Research: mallinckrodt
Keyword Research: People who searched mallinckrodt also searched
Search Results related to mallinckrodt on Search Engine
-
Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical …
http://mallinckrodt.com/
WEBOur Products. Building on our heritage and distinctive capabilities, our world-class development and formulation expertise bring medical solutions to the marketplace. As a global specialty pharmaceutical company, Mallinckrodt has been making the complex simple for more than 150 years. Visit the website to learn more.
DA: 40 PA: 78 MOZ Rank: 75
-
Our Products | Mallinckrodt Pharmaceuticals
https://www.mallinckrodt.com/products-landing/
WEBMallinckrodt has a diverse portfolio of branded products available across a broad range of indications and a broad line of speciality generics. Visit our website to learn about our product offerings.
DA: 85 PA: 5 MOZ Rank: 19
-
Mallinckrodt - Wikipedia
https://en.wikipedia.org/wiki/Mallinckrodt
WEBMallinckrodt Pharmaceuticals is an American-Irish domiciled manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents. In 2017, it generated 90% of its sales from the U.S. healthcare system.
DA: 16 PA: 65 MOZ Rank: 28
-
Careers | Mallinckrodt Pharmaceuticals
https://www.mallinckrodt.com/careers/
WEBAt Mallinckrodt, we're always looking for qualified and motivated individuals to strengthen and energize our team of highly talented individuals. Search career opportunities here.
DA: 42 PA: 38 MOZ Rank: 72
-
Our Story | Mallinckrodt Pharmaceuticals
https://www.mallinckrodt.com/about/our-story/
WEBMallinckrodt Pharmaceuticals spins off from Covidien, becoming an independent, $2 billion public company that develops, manufactures, markets, and distributes specialty pharmaceutical products and diagnostic imaging agents. …
DA: 88 PA: 5 MOZ Rank: 41
-
Get to Know Our Specialty Pharmaceutical Company | Mallinckrodt
https://www.mallinckrodt.com/about
WEBMallinckrodt Pharmaceuticals is a multibillion-dollar specialty pharmaceutical company focused on our mission: Listening for needs. Delivering solutions. We provide medicines and therapies to address unmet patient needs, stemming from 150 years of using our unique strengths, experience, and expertise to help improve people’s lives.
DA: 82 PA: 62 MOZ Rank: 87
-
Drug-maker Mallinckrodt plans to file for bankruptcy a second …
https://www.washingtonpost.com/health/2023/08/23/opioid-manufacturer-mallinckrodt-bankruptcy/
WEBAug 23, 2023 · Drug maker Mallinckrodt, on the hook for more than $1 billion in opioid settlement payments, plans to file for bankruptcy for a second time. The move imperils the $1.7 billion opioid settlement...
DA: 75 PA: 6 MOZ Rank: 32
-
155 Years | Mallinckrodt Pharmaceuticals
https://www.mallinckrodt.com/about/anniversary/
WEBFrom its humble beginnings on a family farm in St. Louis, Missouri, Mallinckrodt has grown to become a global leader in specialty pharmaceuticals on a quest to improve the lives of patients around the world.
DA: 86 PA: 12 MOZ Rank: 44
-
Mallinckrodt Announces U.S. FDA Approval of Supplemental New …
https://ir.mallinckrodt.com/news-releases/news-release-details/mallinckrodt-announces-us-fda-approval-supplemental-new-drug
WEBDUBLIN, March 1, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Mallinckrodt's supplemental New Drug Application (sNDA) for the Acthar ® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector …
DA: 76 PA: 58 MOZ Rank: 69
-
Investor Overview | Mallinckrodt
https://ir.mallinckrodt.com/
WEBJan 19, 2024 · Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides 2024 Guidance Exceeds High End of Guidance Range on Net Sales and Adjusted EBITDA for Fiscal Year Received U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application for Acthar ® Gel (repository …
DA: 68 PA: 18 MOZ Rank: 19
